TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.TherapeuticsMD Inc. (TXMD) shares fell 1.34% to $2.21 on Tuesday, underperforming the broader market as the NASDAQ rose 1.52%. This decline ended a four-day winning streak and left the stock 25.08% below its 52-week high of $2.95. Trading volume exceeded the 50-day average, while competitor AbbVie also saw a slight decrease.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) slid 1.34% to $2.21 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.52% to 26,213.72 and the Dow Jones Industrial Average rising 0.26% to 52,319.20.
The stock's fall snapped a four-day winning streak.
TherapeuticsMD Inc. closed 25.08% short of its 52-week high of $2.95, which the company reached on January 27th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. (ABBV) fell 1.05% to $251.64.
Trading volume (48,481) eclipsed its 50-day average volume of 40,568.
Data source: Dow Jones Market Data, FactSet. Data compiled June 30, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-30-26 1730ET